Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Palisade Bio announced FDA clearance of its Investigational New Drug application for PALI-2108, enabling initiation of a Phase 2 clinical trial (ASCENTRA-CD) in moderate to severe Crohn's disease. The trial targets approximately 60 patients, with first dosing anticipated in Q1 2027 and efficacy readout expected in Q1 2028. PALI-2108 is a novel oral…
MYR Group's pivot toward Commercial & Industrial (C&I) projects and recurring service revenues, plus two strategic acquisitions, helped deliver record Q2 revenues of $1.08B, an 88% jump in EPS, and a 170 bp gross margin expansion. With a $3.16B backlog and low leverage, the stock looks buyable around $288.56. This trade idea lays out an entry at $2…
Polyrizon Ltd., a clinical-stage biotech company listed on Nasdaq as PLRZ, has enrolled its first patient in a U.S. clinical study evaluating NASARIX (PL-14), a drug-free, intranasal hydrogel allergy blocker designed to reduce symptoms of seasonal allergic rhinitis. This milestone signifies the company's move into clinical development, aiming to of…
Idaho Copper Corporation received the U.S. Forest Service's approval for its Exploration Plan of Operations and 2026 annual operating plan, enabling the company to commence drilling activities at its CuMo copper-molybdenum-silver project in Boise County, Idaho. This clears the regulatory path after a decade of work and signals a transition toward a…
Lakeland Industries, Inc., through its independent service provider Colorado PPE, has opened a new facility in Centennial, Colorado. The facility offers comprehensive services for firefighter personal protective equipment (PPE) including cleaning, inspection, repair, rental, and NFPA 1850 training, aiming to exceed industry standards to better prot…
Vistagen announced positive preliminary data from the open-label extension portion of its PALISADE-4 Phase 3 study evaluating fasedienol for acute treatment of social anxiety disorder. The nasal spray was well-tolerated with no new safety issues during up to 12 months of as-needed use. Exploratory efficacy assessments showed clinically relevant imp…
Abercrombie & Fitch announced an expanded partnership with the Dallas Cowboys and Dallas Cowboys Cheerleaders, extending its role as the Official Fashion Partner for a second year. The collaboration introduces new product lines, year-round fan activations, athlete collaborations, and increased distribution through NFLShop and AT&T Stadium. The part…
Aprea Therapeutics announced that updated interim results from its Phase 1 trial of the WEE1 inhibitor APR-1051 in advanced solid tumors will be presented orally at the 38th EORTC-NCI-AACR Symposium. The data presentation highlights progress in their targeted cancer therapy pipeline, potentially impacting multiple tumor types including ovarian, col…
Zeo Energy Corp. has entered a cooperation agreement with Ewyze Corp. to jointly develop and commercialize integrated off-grid power microgrids combined with data-center infrastructure in the U.S. and selected international markets. This partnership addresses the growing demand for AI-capable, reliable, and scalable power solutions amid challenges …
Compass Therapeutics announced that the FDA recommended conducting an additional trial to prove a survival benefit for its drug tovecimig in advanced biliary tract cancer prior to Biologics License Application submission. Compass disagrees with the FDA's recommendation, citing positive Phase 2/3 trial results showing significant improvements in obj…
Quoin Pharmaceuticals announced the FDA granted Fast Track Designation for QRX003 to treat Peeling Skin Syndrome (PSS), a rare genetic skin disease with no approved therapies. This is the first Fast Track granted for PSS treatment and the second for QRX003, which also has Fast Track status for Netherton Syndrome. Following FDA clearance of the firs…
Grayscale Investments has introduced the Grayscale AI Compute ETF (GCPU), targeting companies involved in the physical infrastructure critical to AI's rapid expansion. The new fund tracks the Indxx High Performance Computing Index and provides exposure to firms building and transitioning operations toward AI workloads, reflecting a projected $1 tri…
Marchex, Inc. announces engagement with investor relations firm PondelWilkinson to support an expanded IR program aimed at increasing institutional investor awareness and supporting its growth strategy following the acquisition of Archenia. This acquisition broadens Marchex's capabilities in AI-driven customer acquisition and optimization, position…
Propanc Biopharma, Inc. highlights new preclinical data demonstrating that its lead candidate PRP achieves over 90% tumor growth inhibition and more than 2.5-fold survival benefit in pancreatic ductal adenocarcinoma (PDAC) models. PRP works by promoting cancer cell differentiation and reversing mechanisms like EMT and cancer stem cell presence, whi…
SAB Biotherapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq (SABS), announced multiple presentations featuring their lead candidate SAB-142 at the 62nd European Association for the Study of Diabetes meeting. SAB-142 is a novel, human anti-thymocyte immunoglobulin therapy showing potential to modify disease progression in Stage …
Fiserv announces that its Clover commerce platform has been selected by the Winnipeg Blue Bombers to manage commerce operations at their stadium, marking a significant expansion of Fiserv's presence in Canada’s sports, entertainment, and hospitality sectors. Clover supports multiple Canadian Football League venues and offers integrated payment proc…
Natural gas strength and accelerating LNG exports underpin Cheniere’s cash flow, but the stock has pulled back into a reasonable buy zone. With a market cap near $56.8B, stable free cash flow and constructive contract-backed volumes, this is a buy-the-dip swing trade with disciplined stops and a clear catalyst calendar.
Societe Generale's Capital Markets Day on 09/21/2026 largely confirmed the bank's prior strategy: cost control, gradual capital returns and incremental de-risking. Management offered no materially new levers to accelerate return on tangible equity or earnings growth. That leaves the stock exposed to a re-rating if macro momentum stalls or investors…
Bank of America analysts have lifted their Brent crude price projection for the second half of 2026 to $95 a barrel from $83, citing sustained geopolitical tensions and notable disruptions to key oil chokepoints. The bank highlights sharply reduced flows through the Strait of Hormuz, alternative route constraints, and clashes at the Bab el-Mandeb a…
A senior Iranian official said Iran could reopen the Strait of Hormuz to Gulf shipping within days if the United States removes its blockade, describing upcoming United Nations meetings as a key chance to renew diplomacy. With both presidents expected at the UN General Assembly, Tehran says its delegation has authority to restart talks and has tran…
Scienture Holdings, Inc. announced an exclusive sales, marketing, and distribution agreement to distribute its FDA-approved REZENOPY™ naloxone hydrochloride nasal spray through a partner's network of approximately 2,000 Opioid Treatment Program (OTP) clinics and addiction treatment centers across the United States. The agreement complements Scientu…
Xenon Pharmaceuticals' lead candidate azetukalner posted convincing Phase 3 seizure reductions and an NDA was submitted 09/18/2026. The stock has sold off after a temporary pause in depression studies, creating a volatile entry point. This trade idea lays out a mid-term swing (45 trading days) long with a clear entry, stop and target while framing …
TriplePoint Venture Growth (TPVG) trades at a heavy discount to book with a published quarterly distribution of $0.29 and a cited yield near 19%. Balance-sheet leverage and short interest create volatility, but low valuation multiples (P/E ~6, P/B ~0.56) and positive free cash flow give upside to shareholders who collect the payout and wait for NAV…
Top Wealth Group Holding Limited, a NASDAQ-listed premium caviar and wine supplier, announced the relocation of its global headquarters from Hong Kong to Lille, France. This strategic move supports the company's shift from a regional Asian focus to a wider global luxury food and beverage market presence. The relocation aims to enhance distribution …
IMUNON's DNA-based immunotherapy candidate IMNN-001 demonstrated a favorable safety profile with no serious immune-related adverse events in an ongoing Phase 2 minimal residual disease (MRD) study for advanced ovarian cancer. The Independent Data Monitoring Committee recommended continuation without modifications, validating the drug's tolerability…
